يعرض 1 - 20 نتائج من 3,031 نتيجة بحث عن '(( pan cancer decrease ) OR ( a ((marked decrease) OR (larger decrease)) ))', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Biases in larger populations. حسب Sander W. Keemink (21253563)

    منشور في 2025
    "…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …"
  14. 14
  15. 15
  16. 16
  17. 17

    Table 1_Pan-cancer multi-omics analysis of CCT4 in tumor progression and cancer immunity, with focus on lung adenocarcinoma.docx حسب Yonghui Wu (171826)

    منشور في 2025
    "…</p>Methods<p>To address this gap, we integrated transcriptomics, proteomics, genomics, epigenetics and immunogenomics data. A comprehensive pan-cancer analysis was conducted (including the expression patterns, clinical relevance, prognosis value, immune infiltration of pan-cancer). …"
  18. 18

    Data Sheet 1_Pan-cancer multi-omics analysis of CCT4 in tumor progression and cancer immunity, with focus on lung adenocarcinoma.docx حسب Yonghui Wu (171826)

    منشور في 2025
    "…</p>Methods<p>To address this gap, we integrated transcriptomics, proteomics, genomics, epigenetics and immunogenomics data. A comprehensive pan-cancer analysis was conducted (including the expression patterns, clinical relevance, prognosis value, immune infiltration of pan-cancer). …"
  19. 19

    Data Sheet 1_The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer.docx حسب Anqi Wu (3413069)

    منشور في 2024
    "…Introduction<p>Aldo-keto reductase 1B10 (AKR1B10) is a multifunctional enzyme, which is important in cancer development and progression, but the landscape of AKR1B10 in pan-cancers and in tumor microenvironment is unclear.…"
  20. 20

    Supplementary file 2_Immune indicators as predictors of cancer-related fatigue: a risk prediction model in pan-cancer patients.docx حسب Guixin He (2547469)

    منشور في 2025
    "…This study aimed to identify immune and clinical factors associated with CRF in a pan-cancer cohort and to develop a predictive model for CRF to inform personalized clinical management.…"